Home > News > The IPO Market's Golden Mean?
August 9th, 2004
Abstract:
Venture capitalists have argued that many nanotech concerns, like biotechs before them, will come to the public markets early in their lifetimes because their work is so capital-intensive that they'll need the kind of resources only Wall Street can provide. But so far, the market isn't ready to bet aggressively on early-stage research many institutional investors barely grasp.
Source:
businessweek
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||